ClinicalTrials.Veeva

Menu

Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa

H

Hospital Sao Domingos

Status

Unknown

Conditions

Severe Sepsis
Septic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT01841190
hsd1509

Details and patient eligibility

About

The purpose of this study is to compare the tendency of plasma concentration and clearance of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis and septic shock with another marker of early prognosis represented by 48 hours delta sofa.

Full description

This is a cohort prospective observational study that will include adult patients admitted to a multidisciplinary ICU of a tertiary hospital.

Enrollment

128 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients admitted to the ICU
  • severe sepsis and septic shock

Exclusion criteria

  • Children
  • Pregnant.

Trial design

128 participants in 2 patient groups

PROCALCITONIN
DELTA SOFA

Trial contacts and locations

2

Loading...

Central trial contact

JOSE R AZEVEDO, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems